note
usd million
usd million
profit for the year
716
1 846
depreciation and amortisation
765
720
impairment of non-current assets
366
370
net foreign exchange loss
85
111
-gain/loss on disposal of property plant and equipment
-4
23
share of profits of associates and joint ventures
-752
-1 553
income tax expense
160
607
-partial reversal of provision / write-down of inventories to
net realisable value
-14
172
impairment of trade and other receivables
16
169
provision for legal claims
3
10
change in fair value of derivative financial instruments
99
191
change in fair value of financial assets and liabilities
94
-31
operating profit before changes in working capital
2162
3 470
decrease/-increase in inventories
843
-1 098
decrease/-increase in trade and other receivables and
decrease in trade and other payables and advances received
-259
-783
cash flows from operations before income tax
3086
1 171
income taxes paid
-365
-599
cash flows from operating activities
2721
572
the consolidated statement of cash flows is to be read in conjunction with the notes to and forming part of
the consolidated financial statements set out on pages 15 to 83
consolidated statement of cash flows
for the year ended 31 december 2023 -continued
year ended 31 december
2023
2 022
note
usd million
usd million
proceeds from disposal of property plant and equipment
13
8
acquisition of property plant and equipment
-1413
-1 674
acquisition of intangible assets
-35
-37
cash paid for investment in equity securities measured at
fair value through profit and loss
-5
-113
cash -paid for / received from other investments
-69
111
dividends from associates and joint ventures
−
1 639
dividends from financial assets
23
34
prepayment for acquisition of associate
-13
−
contribution to associates and joint ventures
-5
-8
cash outflow from disposal of subsidiary
−
-16
change in restricted cash
1
-1
cash flows -used in / from investing activities
-1419
47
proceeds from borrowings
6103
9 129
repayment of borrowings
-7662
-7 007
acquisition of non-controlling interest
-3
-14
restructuring fees
-31
-21
settlement of derivative financial instruments
-2
-229
dividends to non-controlling shareholders
−
-129
cash flows -used in / from financing activities
-2277
742
net -decrease/increase in cash and cash equivalents
-975
1 361
cash and cash equivalents at beginning of the year
excluding restricted cash
3474
2 328
effect of exchange rate changes on cash and cash equivalents
-154
-215
cash and cash equivalents at end of the year
excluding restricted cash
2345
3 474